Stockscreener 앱 받기
97.95
2.40%
2.30
시간 외 거래:
97.95
전일 마감가:
$95.65
열려 있는:
$98.245
하루 거래량:
702.60K
Relative Volume:
0.81
시가총액:
$5.91B
수익:
$521.31M
순이익/손실:
$-23.36M
주가수익비율:
-204.87
EPS:
-0.4781
순현금흐름:
$54.87M
1주 성능:
+3.52%
1개월 성능:
+13.50%
6개월 성능:
+34.45%
1년 성능:
+149.11%
1일 변동 폭
$96.21
$98.63
1주일 범위
$92.37
$98.63
52주 변동 폭
$36.88
$109.28
Mirum Pharmaceuticals Inc Stock (MIRM) Company Profile
명칭
Mirum Pharmaceuticals Inc
전화
650-667-4085
주소
989 EAST HILLSDALE BOULEVARD, SUITE 300, FOSTER CITY
Compare MIRM vs VRTX, REGN, ARGX, ALNY, ONC
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
MIRM
Mirum Pharmaceuticals Inc
|
97.95 | 5.77B | 521.31M | -23.36M | 54.87M | -0.4781 |
VRTX
Vertex Pharmaceuticals Inc
|
443.92 | 109.85B | 12.07B | 3.95B | 3.19B | 15.33 |
REGN
Regeneron Pharmaceuticals Inc
|
775.53 | 80.38B | 14.34B | 4.50B | 3.77B | 41.56 |
ARGX
Argen X Se Adr
|
785.07 | 47.60B | 4.16B | 1.29B | 734.26M | 19.58 |
ALNY
Alnylam Pharmaceuticals Inc
|
327.25 | 42.63B | 3.71B | 313.75M | 465.38M | 2.2571 |
ONC
Beone Medicines Ltd Adr
|
312.19 | 33.72B | 5.36B | 287.73M | 924.18M | 2.5229 |
Mirum Pharmaceuticals Inc Stock (MIRM) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2026-02-18 | 개시 | RBC Capital Mkts | Outperform |
| 2025-09-24 | 개시 | TD Cowen | Buy |
| 2025-08-11 | 재개 | Stifel | Buy |
| 2025-05-19 | 재개 | H.C. Wainwright | Buy |
| 2024-04-17 | 개시 | Stifel | Buy |
| 2023-12-18 | 재확인 | H.C. Wainwright | Buy |
| 2023-11-20 | 재개 | JP Morgan | Overweight |
| 2023-11-13 | 개시 | Morgan Stanley | Overweight |
| 2023-10-24 | 개시 | Cantor Fitzgerald | Overweight |
| 2023-10-17 | 재개 | Evercore ISI | Outperform |
| 2023-09-20 | 개시 | JMP Securities | Mkt Outperform |
| 2022-09-01 | 개시 | Citigroup | Buy |
| 2021-09-20 | 개시 | JP Morgan | Overweight |
| 2020-08-07 | 업그레이드 | Raymond James | Outperform → Strong Buy |
| 2020-08-03 | 개시 | H.C. Wainwright | Buy |
| 2020-07-31 | 개시 | Piper Sandler | Overweight |
| 2020-06-25 | 개시 | Robert W. Baird | Outperform |
| 2019-08-12 | 개시 | Citigroup | Buy |
| 2019-08-12 | 개시 | Evercore ISI | Outperform |
| 2019-08-12 | 개시 | Guggenheim | Buy |
| 2019-08-12 | 개시 | ROTH Capital | Buy |
| 2019-08-12 | 개시 | Raymond James | Outperform |
모두보기
Mirum Pharmaceuticals Inc 주식(MIRM)의 최신 뉴스
Mirum (MIRM) details Bluejay deal and $268.5M PIPE financing - Stock Titan
Primary Sclerosing Cholangitis Market is expected to Hit US$ - openPR.com
18,710 Shares in Mirum Pharmaceuticals, Inc. $MIRM Purchased by SG Americas Securities LLC - MarketBeat
Mirum Pharmaceuticals, Inc. (MIRM) Surpasses Q3 Earnings and Revenue Estimates - MSN
Mirum (MIRM) Q1 2025 Earnings Call Transcript - AOL.com
MIRM Financials: Revenue Breakdown, Margins & Competitor Comparison - intellectia.ai
MIRM PE Ratio & Valuation, Is MIRM Overvalued - Intellectia AI
Mirum Pharmaceuticals, Inc. (NASDAQ:MIRM) Receives Average Rating of "Moderate Buy" from Analysts - MarketBeat
Mirum Pharmaceuticals, Inc. (MIRM) stock price, news, quote and history - Yahoo Finance UK
Mirum Pharmaceuticals, Inc. (MIRM) Stock Price, News, Quote & History - Yahoo! Finance Canada
Mirum Pharmaceuticals (MIRM) Moves 5.1% Higher: Will This Strength Last? - qz.com
Mirum Pharmaceuticals (MIRM) Rises 5.1%: Can This Upward Momentum Continue? - Bitget
Mirum Pharma (MIRM) Earnings Call Transcript - The Globe and Mail
JPMorgan Chase & Co. Sells 380,067 Shares of Mirum Pharmaceuticals, Inc. $MIRM - marketbeat.com
(MIRM) and the Role of Price-Sensitive Allocations - Stock Traders Daily
US Stocks Recap: Will Mirum Pharmaceuticals Inc stock hit new highs in YEARWeekly Profit Report & Fast Momentum Stock Entry Tips - baoquankhu1.vn
Does Mirum Pharmaceuticals Inc stock benefit from AI growth2026 Earnings & Short-Term Trading Opportunity Alerts - baoquankhu1.vn
A Look At Mirum Pharmaceuticals (MIRM) Valuation After Strong Long Term Share Performance - Yahoo Finance
Hennion & Walsh Asset Management Inc. Sells 17,560 Shares of Mirum Pharmaceuticals, Inc. $MIRM - MarketBeat
Tudor Investment Corp ET AL Makes New $2.03 Million Investment in Mirum Pharmaceuticals, Inc. $MIRM - MarketBeat
Mirum Pharmaceuticals Stock: Pipeline Progress and Rare Disease Focus for Long-Term Investor Value - AD HOC NEWS
Energy Moves: Will Mirum Pharmaceuticals Inc benefit from AI trendsWeekly Market Summary & Expert Approved Momentum Trade Ideas - baoquankhu1.vn
Mirum Pharmaceuticals (NASDAQ:MIRM) Price Target Raised to $125.00 - MarketBeat
Why Is Mirum Pharmaceuticals (MIRM) Down 3.6% Since Last Earnings Report? - finance.yahoo.com
Vanguard disaggregates holdings; Mirum (MIRM) shows 0 shares owned - stocktitan.net
Mirum Pharmaceuticals Insiders Sell US$1.6m Of Stock, Possibly Signalling Caution - 富途牛牛
TD Cowen raises Mirum Pharmaceuticals stock price target to $125 - Investing.com
TD Cowen Maintains Mirum Pharmaceuticals(MIRM.US) With Buy Rating, Raises Target Price to $125 - Moomoo
Citizens reiterates Mirum Pharmaceuticals stock rating on HDV data By Investing.com - Investing.com Canada
Citizens reiterates Mirum Pharmaceuticals stock rating on HDV data - Investing.com
Investor Mood: What are analysts price targets for Mirum Pharmaceuticals Inc2026 Institutional Moves & High Accuracy Trade Alerts - baoquankhu1.vn
Mirum completes enrollment & screening in liver disease studies - MSN
Citizens reiterates Mirum Pharmaceuticals stock rating ahead of data By Investing.com - Investing.com Canada
Citizens reiterates Mirum Pharmaceuticals stock rating ahead of data - Investing.com
Mirum Pharmaceuticals (NASDAQ:MIRM) Receives Buy Rating from HC Wainwright - marketbeat.com
Mirum Gains 35% in 3 Months: How Should You Play the Stock? - MSN
Is Mirum Pharmaceuticals (NASDAQ:MIRM) Stabilizing After Rating Updates? - Kalkine Media
Mirum Pharmaceuticals (MIRM) completes enrollment for phase 3 EXPAND study of LIVMARLI - MSN
Baird updates Mirum Pharmaceuticals (MIRM) valuation following beat-and-raise earnings results - MSN
Biotech Stock Up 372% Gets Sold as New Pick Rises 40% in 2026 - The Motley Fool
Mirum Pharmaceuticals (MIRM) Completes Enrollment for Phase 3 EXPAND Study of LIVMARLI - Insider Monkey
Responsive Playbooks and the MIRM Inflection - Stock Traders Daily
MIRM SEC FilingsMirum Pharmaceuticals 10-K, 10-Q, 8-K Forms - Stock Titan
5 Most Promising Stocks Under $100 to Buy - Insider Monkey
RBC Capital initiates coverage of Mirum Pharmaceuticals (MIRM) with outperform recommendation - MSN
Why Mirum Pharmaceuticals Stock Is Sinking Today - TipRanks
Penn Capital Management Company LLC Sells 34,265 Shares of Mirum Pharmaceuticals, Inc. $MIRM - MarketBeat
Mirum EXPAND Enrollment Milestone Highlights LIVMARLI Upside And Valuation Gap - Yahoo Finance
Mirum Pharmaceuticals (NASDAQ:MIRM) Insider Joanne Quan Sells 7,287 Shares - MarketBeat
Insider Selling: Mirum Pharmaceuticals (NASDAQ:MIRM) COO Sells 16,515 Shares of Stock - MarketBeat
Mirum Pharmaceuticals (NASDAQ:MIRM) SVP Jolanda Howe Sells 4,732 Shares - MarketBeat
Mirum Pharmaceuticals Inc (MIRM) 재무 분석
매출
순이익
현금흐름
주당 순 이익
1.51%
1.75%
자본화:
|
볼륨(24시간):